Sudden cardiac death (SCD) is an unresolved health issue, and responsible for 15% of all deaths in Western countries. Epidemiologic evidence, as well as evidence from clinical trials, indicates that increasing intake and high levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) protect from SCD and other major adverse cardiac events. Levels of EPA+DHA are best assessed by the Omega-3 Index, representing the red cell fatty acid content of EPA+DHA. Work is in progress that will further define the value of the Omega-3 Index as a risk factor for SCD, other cardiac events, and as target for treatment with EPA+DHA.
References
[1]
Zipes, D.P.; Camm, A.J.; Borggrefe, M.; Buxton, A.E.; Chaitman, B.; Fromer, M.; Gregoratos, G.; Klein, G.; Moss, A.J.; Myerburg, R.J.; Priori, S.G.; Quinones, M.A.; Roden, D.M.; Silka, M.J.; Tracy, C.; Smith, S.C., Jr.; Jacobs, A.K.; Adams, C.D.; Antman, E.M.; Anderson, J.L.; Hunt, S.A.; Halperin, J.L.; Nishimura, R.; Ornato, J.P.; Page, R.L.; Riegel, B.; Blanc, J.J.; Budaj, A.; Dean, V.; Deckers, J.W.; Despres, C.; Dickstein, K.; Lekakis, J.; McGregor, K.; Metra, M.; Morais, J.; Osterspey, A.; Tamargo, J.L.; Zamorano, J.L. American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation？2006, 114, e385–e484. 16935995
[2]
Al-Khatib, S.M.; Sanders, G.D.; Carlson, M.; Cicic, A.; Curtis, A.; Fonarow, G.C.; Groeneveld, P.W.; Hayes, D.; Heidenreich, P.; Mark, D.; Peterson, E.; Prystowsky, E.N.; Sager, P.; Salive, M.E.; Thomas, K.; Yancy, C.W.; Zareba, W.; Zipes, D. Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. Am. Heart J.？2008, 156, 613–622.
[3]
Bardy, G.H.; Lee, K.L.; Mark, D.B.; Poole, J.E.; Toff, W.D.; Tonkin, A.M.; Smith, W.; Dorian, P.; Packer, D.L.; White, R.D.; Longstreth, W.T., Jr.; Anderson, J.; Johnson, G.; Bischoff, E.; Yallop, J.J.; McNulty, S.; Ray, L.D.; Clapp-Channing, N.E.; Rosenberg, Y.; Schron, E.B. HAT Investigators. Home use of automated external defibrillators for sudden cardiac arrest. N. Engl. J. Med.？2008, 358, 1793–1804. 18381485
[4]
Epstein, A.E.; DiMarco, J.P.; Ellenbogen, K.A.; Estes, N.A., 3rd.; Freedman, R.A.; Gettes, L.S.; Gillinov, A.M.; Gregoratos, G.; Hammill, S.C.; Hayes, D.L.; Hlatky, M.A.; Newby, L.K.; Page, R.L.; Schoenfeld, M.H.; Silka, M.J.; Stevenson, L.W.; Sweeney, M.O.; Smith, S.C., Jr.; Jacobs, A.K.; Adams, C.D.; Anderson, J.L.; Buller, C.E.; Creager, M.A.; Ettinger, S.M.; Faxon, D.P.; Halperin, J.L.; Hiratzka, L.F.; Hunt, S.A.; Krumholz, H.M.; Kushner, F.G.; Lytle, B.W.; Nishimura, R.A.; Ornato, J.P.; Page, R.L.; Riegel, B.; Tarkington, L.G.; Yancy, C.W. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation？2008, 117, e350–e408. 18483207
[5]
Steinbeck, G.; Andresen, D.; Seidl, K.; Brachmann, J.; Hoffmann, E.; Wojciechowski, D.; Kornacewicz-Jach, Z.; Sredniawa, B.; Lupkovics, G.; Hofg？rtner, F.; Lubinski, A.; Rosenqvist, M.; Habets, A.; Wegscheider, K.; Senges, J. IRIS Investigators. Defibrillator implantation early after myocardial infarction. N. Engl. J. Med.？2009, 361, 1427–1436. 19812399
[6]
Sackner-Bernstein, J. Reducing the risks of sudden death and heart failure post myocardial infarction, utility of optimized pharmacotherapy. Clin. Cardiol.？2005, 11, 119–127.
[7]
Harris, W.S.; von Schacky, C. The Omega-3 Index: a new risk factor for death from coronary heart disease ? Prev. Med.？2004, 39, 212–220, doi:10.1016/j.ypmed.2004.02.030. 15208005
[8]
Harris, W.S.; von Schacky, C.; Park, Y. Establishing uniform analytical methods for RBC omega-3 fatty acids: an intercontinental pilot study. In ISSFAL 2008, Proceedings of ISSFAL 2008, Kansas City, MO, USA, 2008; p. 78.
[9]
Harris, W.S. The omega-3 index as a risk factor for coronary heart disease. Am. J. Clin. Nutr.？2008, 87, 1997S–2002S.
Harris, W.S.; Sands, S.A.; Windsor, S.L.; Ali, H.A.; Stevens, T.L.; Magalski, A.; Porter, C.B.; Borkon, A.M. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation？2004, 110, 1645–1649.
[12]
Metcalf, R.G.; James, M.J.; Gibson, R.A.; Edwards, J.R.; Stubberfield, J.; Stuklis, R.; Roberts-Thomson, K.; Young, G.D.; Cleland, L.G. Effects of fish-oil supplementation on myocardial fatty acids in humans. Am. J. Clin. Nutr.？2007, 85, 1222–1228.
[13]
Metcalf, R.G.; Cleland, L.G.; Gibson, R.A.; Roberts-Thomson, K.C.; Edwards, J.R.M.; Sanders, P.; Stuklis, R.; James, M.J.; Young, G.D. Relation between blood and atrial fatty acids in patients undergoing cardiac bypass surgery. Am. J. Clin. Nutr.？2010, 91, 528–534.
[14]
von Schacky, C.; Fischer, S.; Weber, P.C. Long term effects of dietary marine omega-3 fatty acids upon plasma- and cellular lipids, platelet function and eicosanoid formation in humans. J. Clin. Invest.？1985, 76, 1626–1631, doi:10.1172/JCI112147. 2997286
[15]
von Schacky, C.; Weber, P.C. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J. Clin. Invest.？1985, 76, 2446–2450, doi:10.1172/JCI112261. 3001149
[16]
Sands, S.A.; Reid, K.J.; Windsor, S.L.; Harris, W.S. The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids？2005, 40, 343–347, doi:10.1007/s11745-006-1392-2. 16028715
[17]
Itomura, M.; Fujioka, S.; Hamazaki, K.; Kobayashi, K.; Nagasawa, T.; Sawazaki, S.; Kirihara, Y.; Hamazaki, T. Factors influencing EPA+DHA levels in red blood cells in Japan. In Vivo.？2008, 22, 131–135.
[18]
di Giuseppe, R.; de Lorgeril, M.; Salen, P.; Laporte, F.; Di Castelnuovo, A.; Krogh, V.; Siani, A.; Arnout, J.; Cappuccio, F.P.; van Dongen, M.; Donati, M.B.; de Gaetano, G.; Iacoviello, L. European Collaborative Group of the IMMIDIET Project. Alcohol consumption and n-3 polyunsaturated fatty acids in healthy men and women from 3 European populations. Am. J. Clin. Nutr.？2009, 89, 354–362. 19056552
[19]
Cohen, B.E.; Garg, S.K.; Ali, S.; Harris, W.S.; Whooley, M.A. Red blood cell docosahexaenoic acid and eicosapentaenoic acid concentrations are positively associated with socioeconomic status in patients with established coronary artery disease: data from the Heart and Soul Study. J. Nutr.？2008, 138, 1135–1140.
[20]
Plourde, M.; Cunnane, S.C. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl. Physiol. Nutr. Metab.？2007, 32, 619–634.
[21]
von Schacky, C. Omega-3 fatty acids vs. cardiac disease – the contribution of the Omega-3 Index. Cell. Mol. Biol.？2010, 56, 90–98.
[22]
von Schacky, C. Cardiovascular disease prevention and treatment. Prostaglandins Leukot Essent Fatty Acids？2009, 81, 193–198.
[23]
Iso, H.; Kobayashi, M.; Ishihara, J.; Sasaki, S.; Okada, K.; Kita, Y.; Kokubo, Y.; Tsugane, S. JPHC Study Group. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation？2006, 113, 195–202. 16401768
[24]
Siscovick, D.S.; Raghunathan, T.E.; King, I.; Weinmann, S.; Wicklund, K.G.; Albright, J.; Bovbjerg, V.; Arbogast, P.; Smith, H.; Kushi, L.H. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the riskof primary cardiac arrest. J. Am. Med. Assoc.？1995, 275, 836–837.
[25]
Albert, C.M.; Campos, H.; Stampfer, M.J.; Ridker, P.M.; Manson, J.E.; Willett, W.C.; Ma, J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med.？2002, 346, 1113–1118.
[26]
Streppel, M.T.; Ocké, M.C.; Boshuizen, H.C.; Kok, F.J.; Kromhout, D. Long-term fish consumption and n-3 fatty acid intake in relation to (sudden) coronary heart disease death: the Zutphen study. Eur. Heart J.？2008, 16, 2024–2030.
[27]
Ueshima, H. Explanation for the Japanese paradox: Reduction of increase in coronary heart disease and reduction in stroke. J. Atheroscl. Thromb.？2007, 14, 278–286.
[28]
Sekikawa, A.; Curb, J.D.; Ueshima, H.; El-Saed, A.; Kadowaki, T.; Abbott, R.D.; Evans, R.W.; Rodriguez, B.L.; Okamura, T.; Sutton-Tyrrell, K.; Nakamura, Y.; Masaki, K.; Edmundowicz, D.; Kashiwagi, A.; Willcox, B.J.; Takamiya, T.; Mitsunami, K.; Seto, T.B.; Murata, K.; White, R.L.; Kuller, L.H. ERA JUMP (Electron-Beam Tomography, Risk Factor Assessment Among Japanese and U.S. Men in the Post-World War II Birth Cohort) Study Group. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J. Am. Coll. Cardiol.？2008, 52, 417–424. 18672160
[29]
Virtanen, J.K.; Mozaffarian, D.; Chiuve, S.E.; Rimm, E.B. Fish consumption and risk for major chronic disease in men. Am. J. Clin. Nutr.？2008, 88, 1618–1625.
[30]
London, B.; Albert, C.; Anderson, M.E.; Giles, W.R.; Van Wagoner, D.R.; Balk, E.; Billman, G.E.; Chung, M.; Lands, W.; Leaf, A.; McAnulty, J.; Martens, J.R.; Costello, R.B.; Lathrop, D.A. Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. Circulation？2007, 116, e320–335. 17768297
[31]
Den Ruijter, H.M.; Berecki, G.; Verkerk, A.O.; Bakker, D.; Baartscheer, A.; Schumacher, C.A.; Belterman, C.N.; de Jonge, N; Fiolet, J.W.; Brouwer, I.A.; Coronel, R. Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure. Circulation？2008, 117, 536–44. 18195172
[32]
Mozaffarian, D.; Geelen, A.; Brouwer, I.A.; Geleijnse, J.M.; Zock, P.L.; Katan, M.B. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation？2005, 112, 1945–1952.
[33]
von Schacky, C. Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both? Curr. Opin. Clin. Nutr. Metab. Care.？2008, 11, 94–99, doi:10.1097/MCO.0b013e3282f44bdf. 18301082
[34]
Schrepf, R.; Limmert, T.; Weber, P.C.; Theisen, K.; Sellmayer, A. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet？2004, 363, 1441–1442, doi:10.1016/S0140-6736(04)16105-9. 15121409
[35]
Metcalf, R.G.; Sanders, P.; James, M.J.; Cleland, L.G.; Young, G.D. Effect of dietary n-3 polyunsaturated fatty acids on the inducibility of ventricular tachycardia in patients with ischemic cardiomyopathy. Am. J. Cardiol.？2008, 101, 758–761.
Aarset？y, H.; P？nitz, V.; Nilsen, O.B.; Grundt, H.; Harris, W.S.; Nilsen, D.W. Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction. Resuscitation？2008, 78, 258–264.
[38]
Wilhelm, M.; Tobias, R.; Asskali, F.; Kraehner, R.; Kuly, S.; Klinghammer, L.; Boehles, H.; Daniel, W.G. Red blood cell omega-3 fatty acids and the risk of ventricular arrhythmias in patients with heart failure. Am. Heart J.？2008, 155, 971–977.
[39]
Poole, J.E.; Johnson, G.W.; Hellkamp, A.S.; Anderson, J.; Callans, D.J.; Raitt, M.H.; Reddy, R.K.; Marchlinski, F.E.; Yee, R.; Guarnieri, T.; Talajic, M.; Wilber, D.J.; Fishbein, D.P.; Packer, D.L.; Mark, D.B.; Lee, K.L.; Bardy, G.H. Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure. N. Engl. J. Med.？2008, 359, 1009–1017.
[40]
Conolly, S.J. Use and Misuse of Surrogate Outcomes in Arrhythmia Trials. Circulation？2006, 113, 764–766.
[41]
Rauch, B.; Schiele, R.; Schneider, S.; Gohlke, H.; Diller, F.; Gottwik, M.; Steinbeck, G.; Heer, T.; Katus, H.; Zimmer, R.; Erdogan, A.; Pfafferott, C.; Senges, J. Omega-Study Group. Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-study. Cardiovasc. Drugs Ther.？2006, 5, 365–375.
[42]
GISSI-Prevenzione Group. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet？1999, 354, 447–455. 10465168
[43]
Marchioli, R.; Barzi, F.; Bomba, E.; Chieffo, C.; Di Gregorio, D.; Di Mascio, R.; Franzosi, M.G.; Geraci, E.; Levatesi, G.; Maggioni, A.P.; Mantini, L.; Marfisi, R.M.; Mastrogiuseppe, G.; Mininni, N.; Nicolosi, G.L.; Santini, M.; Schweiger, C.; Gavazzi, L.; Tognoni, G.; Tucci, C.; Valagussa, F. GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation？2002, 105, 1897–1903. 11997274
[44]
Burr, M.L.; Fehily, A.M.; Gilbert, J.F.; Rogers, S.; Holliday, R.M.; Sweetnam, P.M.; Elwood, P.C.; Deadman, N.M. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet？1989, 2, 757–761. 2571009
[45]
Burr, M.L.; Ashfield-Watt, P.A.L.; Dunstan, F.D.J.; Fehily, A.M.; Breay, P.; Ashton, T.; Zotos, P.C.; Haboubi, N.A.; Elwood, P.C. Lack of benefit of dietary advice to men with angina, results of a controlled trial. Eur. J. Clin. Nutr.？2003, 57, 193–200.
[46]
Yokoyama, M.; Origasa, H.; Matsuzaki, M.; Matsuzawa, Y.; Saito, Y.; Ishikawa, Y.; Oikawa, S.; Sasaki, J.; Hishida, H.; Itakura, H.; Kita, T.; Kitabatake, A.; Nakaya, N.; Sakata, T.; Shimada, K.; Shirato, K. Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet？2007, 369, 1090–1098. 17398308
[47]
Tavazzi, L.; Maggioni, A.P.; Marchioli, R.; Barlera, S.; Franzosi, M.G.; Latini, R.; Lucci, D.; Nicolosi, G.L.; Porcu, M.; Tognoni, G. Gissi-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet？2008, 372, 1223–1230. 18757090
[48]
Gerstein, H.; Yusuf, S.; Riddle, M.C.; Ryden, L.; Bosch, J. Origin Trial Investigators. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am. Heart J.？2008, 155, 26–32. 18082485
[49]
Leon, H.; Shibata, M.C.; Sivakumaran, S.; Dorgan, M.; Chatterley, T.; Tsuyuki, R.T. Effect of fish oil on arrhythmias and mortality: a systematic review. Br. Med. J.？2009, 338, a2931, doi:10.1136/bmj.a2931.
[50]
Mozaffarian, D.; Rimm, E.B. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA？2006, 296, 1885–1899, doi:10.1001/jama.296.15.1885. 17047219
[51]
Harris, W.S.; Mozaffarian, D.; Lefevre, M.; Toner, C.D.; Colombo, J.; Cunnane, S.C.; Holden, J.M.; Klurfeld, D.M.; Morris, M.C.; Whelan, J. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J. Nutr.？2009, 139, 804S–819S.
[52]
K？hler, A.; Bittner, D.; L？w, A.; von Schacky, C. Effect of a convenience drink fortified with omega-3 fatty acids on the omega-3 index. Br. J. Nutr.？2010. in press.
[53]
Graham, I.; Atar, D.; Borch-Johnsen, K.; Boysen, G.; Burell, G.; Cifkova, R.; Dallongeville, J.; De Backer, G.; Ebrahim, S.; Gjelsvik, B.; Herrmann-Lingen, C.; Hoes, A.; Humphries, S.; Knapton, M.; Perk, J.; Priori, S.G.; Pyorala, K.; Reiner, Z.; Ruilope, L.; Sans-Menendez, S.; Op Reimer, W.S.; Weissberg, P.; Wood, D.; Yarnell, J.; Zamorano, J.L.; Walma, E.; Fitzgerald, T.; Cooney, M.T.; Dudina, A.; Vahanian, A.; Camm, J.; De Caterina, R.; Dean, V.; Dickstein, K.; Funck-Brentano, C.; Filippatos, G.; Hellemans, I.; Kristensen, S.D.; McGregor, K.; Sechtem, U.; Silber, S.; Tendera, M.; Widimsky, P.; Zamorano, J.L.; Altiner, A.; Bonora, E.; Durrington, P.N.; Fagard, R.; Giampaoli, S.; Hemingway, H.; Hakansson, J.; Kjeldsen, S.E.; Larsen, M.L.; Mancia, G.; Manolis, A.J.; Orth-Gomer, K.; Pedersen, T.; Rayner, M.; Ryden, L.; Sammut, M.; Schneiderman, N.; Stalenhoef, A.F.; Tokg？zoglu, L.; Wiklund, O.; Zampelas, A. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur. J. Cardiovasc. Prev. Rehabil.？2007, 14, E1–40. 17726406
[54]
Helfand, M.; Buckley, D.I.; Freeman, M.; Fu, R.; Rogers, K.; Fleming, C.; Humphrey, L.L. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U. S. Preventive Services Task Force. Ann. Intern. Med.？2009, 151, 496–507. 19805772
[55]
Hlatky, M.A.; Greenland, P.; Arnett, D.K.; Ballantyne, C.M.; Criqui, M.H.; Elkind, M.S.; Go, A.S.; Harrell, F.E., Jr; Hong, Y.; Howard, B.V.; Howard, V.J.; Hsue, P.Y.; Kramer, C.M.; McConnell, J.P.; Normand, S.L.; O'Donnell, C.J.; Smith, S.C., Jr; Wilson, P.W. American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation？2009, 119, 2408–2416. 19364974
